乳腺癌
生物
CDH1
PTEN公司
体细胞
转录组
种系突变
外显子组
癌症研究
基因表达谱
基因
拷贝数分析
外显子组测序
外显子
癌症
遗传学
拷贝数变化
突变
基因组
基因表达
PI3K/AKT/mTOR通路
钙粘蛋白
细胞凋亡
细胞
作者
Yuan Chun Ding,Hanbing Song,Aaron W. Adamson,Daniel Schmolze,Donglei Hu,Scott Huntsman,Linda Steele,Carmina S. Patrick,Shu Tao,Natalie Hernandez,Charleen D. Adams,Laura Fejerman,Kevin Gardner,Anna María Nápoles,Eliseo J. Pérez‐Stable,Jeffrey N. Weitzel,Henrik Bengtsson,Franklin W. Huang,Susan L. Neuhausen,Elad Ziv
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2023-05-05
卷期号:83 (15): 2600-2613
被引量:10
标识
DOI:10.1158/0008-5472.can-22-2510
摘要
Abstract Somatic mutational profiling is increasingly being used to identify potential targets for breast cancer. However, limited tumor-sequencing data from Hispanic/Latinas (H/L) are available to guide treatment. To address this gap, we performed whole-exome sequencing (WES) and RNA sequencing on 146 tumors and WES of matched germline DNA from 140 H/L women in California. Tumor intrinsic subtype, somatic mutations, copy-number alterations, and expression profiles of the tumors were characterized and compared with data from tumors of non-Hispanic White (White) women in The Cancer Genome Atlas (TCGA). Eight genes were significantly mutated in the H/L tumors including PIK3CA, TP53, GATA3, MAP3K1, CDH1, CBFB, PTEN, and RUNX1; the prevalence of mutations in these genes was similar to that observed in White women in TCGA. Four previously reported Catalogue of Somatic Mutations in Cancer (COSMIC) mutation signatures (1, 2, 3, 13) were found in the H/L dataset, along with signature 16 that has not been previously reported in other breast cancer datasets. Recurrent amplifications were observed in breast cancer drivers including MYC, FGFR1, CCND1, and ERBB2, as well as a recurrent amplification in 17q11.2 associated with high KIAA0100 gene expression that has been implicated in breast cancer aggressiveness. In conclusion, this study identified a higher prevalence of COSMIC signature 16 and a recurrent copy-number amplification affecting expression of KIAA0100 in breast tumors from H/L compared with White women. These results highlight the necessity of studying underrepresented populations. Significance: Comprehensive characterization of genomic and transcriptomic alterations in breast tumors from Hispanic/Latina patients reveals distinct genetic alterations and signatures, demonstrating the importance of inclusive studies to ensure equitable care for patients. See related commentary by Schmit et al., p. 2443